Stockreport

OVID Slumps 76% on Epilepsy Drug Failing Two Pivotal Studies [Yahoo! Finance]

Ovid Therapeutics Inc.  (OVID) 
Last ovid therapeutics inc. earnings: 3/11 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.ovidrx.com
PDF epilepsy drug, failed to meet the primary endpoint of two pivotal late-stage studies. Ovid's partner Takeda evaluated soticlestat for treating two rare and severe form [Read more]